These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30552114)

  • 21. Synthesis, biological evaluation and docking studies of trans-stilbene methylthio derivatives as cytochromes P450 family 1 inhibitors.
    Wierzchowski M; Dutkiewicz Z; Gielara-Korzańska A; Korzański A; Teubert A; Teżyk A; Stefański T; Baer-Dubowska W; Mikstacka R
    Chem Biol Drug Des; 2017 Dec; 90(6):1226-1236. PubMed ID: 28632937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes.
    Baumgart A; Schmidt M; Schmitz HJ; Schrenk D
    Biochem Pharmacol; 2005 Feb; 69(4):657-67. PubMed ID: 15670584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450 family 1 inhibitors and structure-activity relationships.
    Liu J; Sridhar J; Foroozesh M
    Molecules; 2013 Nov; 18(12):14470-95. PubMed ID: 24287985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.
    Liu J; Taylor SF; Dupart PS; Arnold CL; Sridhar J; Jiang Q; Wang Y; Skripnikova EV; Zhao M; Foroozesh M
    J Med Chem; 2013 May; 56(10):4082-92. PubMed ID: 23600958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of human cytochrome P450 2D6 with prinomastat bound.
    Wang A; Savas U; Hsu MH; Stout CD; Johnson EF
    J Biol Chem; 2012 Mar; 287(14):10834-43. PubMed ID: 22308038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of polycyclic aromatic hydrocarbons with human cytochrome P450 1A1: a CO flash photolysis study.
    Koley AP; Buters JT; Robinson RC; Markowitz A; Friedman FK
    Arch Biochem Biophys; 1996 Dec; 336(2):261-7. PubMed ID: 8954573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Dynamics Simulations of a Cytochrome P450 from
    Faponle AS; Roy A; Adelegan AA; Gauld JW
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34204747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.
    Sridhar J; Goyal N; Liu J; Foroozesh M
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28698457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism.
    Liu J; Ericksen SS; Sivaneri M; Besspiata D; Fisher CW; Szklarz GD
    Arch Biochem Biophys; 2004 Apr; 424(1):33-43. PubMed ID: 15019834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
    Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of cytochrome P450 CYP119 ligand-dependent conformational dynamics by two-dimensional NMR and X-ray crystallography.
    Basudhar D; Madrona Y; Kandel S; Lampe JN; Nishida CR; de Montellano PR
    J Biol Chem; 2015 Apr; 290(16):10000-17. PubMed ID: 25670859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
    Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
    Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
    Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structures of cytochrome P450 2B6 bound to 4-benzylpyridine and 4-(4-nitrobenzyl)pyridine: insight into inhibitor binding and rearrangement of active site side chains.
    Shah MB; Pascual J; Zhang Q; Stout CD; Halpert JR
    Mol Pharmacol; 2011 Dec; 80(6):1047-55. PubMed ID: 21875942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular insights into the role of a distal F240A mutation that alters CYP1A1 activity towards persistent organic pollutants.
    Navrátilová V; Paloncýová M; Berka K; Mise S; Haga Y; Matsumura C; Sakaki T; Inui H; Otyepka M
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2852-2860. PubMed ID: 28780123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of human cytochrome P450 1A1-mediated oxidation of benzo[a]pyrene by NADPH:cytochrome P450 oxidoreductase and cytochrome b5.
    Indra R; Moserova M; Kroftova N; Sulc M; Martinkova M; Adam V; Eckschlager T; Kizek R; Arlt VM; Stiborova M
    Neuro Endocrinol Lett; 2014; 35 Suppl 2():105-13. PubMed ID: 25638374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of substrate binding to cytochrome P450 1A1 using molecular modeling and kinetic analyses: case of residue 382.
    Liu J; Ericksen SS; Besspiata D; Fisher CW; Szklarz GD
    Drug Metab Dispos; 2003 Apr; 31(4):412-20. PubMed ID: 12642467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation.
    Kleiner HE; Vulimiri SV; Reed MJ; Uberecken A; DiGiovanni J
    Chem Res Toxicol; 2002 Feb; 15(2):226-35. PubMed ID: 11849049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of chicken cytochrome P450 1A4 and 1A5: inter-paralog comparisons of substrate preference and inhibitor selectivity.
    Yang J; An J; Li M; Hou X; Qiu X
    Comp Biochem Physiol C Toxicol Pharmacol; 2013 May; 157(4):337-43. PubMed ID: 23474502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin Modulates AhR Activation by Interfering with CYP1A1-Mediated Clearance of AhR Ligands.
    Manzella CR; Ackerman M; Singhal M; Ticho AL; Ceh J; Alrefai WA; Saksena S; Dudeja PK; Gill RK
    Cell Physiol Biochem; 2020 Feb; 54(1):126-141. PubMed ID: 32017483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.